Israel's UroGen to start mid-stage bladder cancer trial
RAANANA, Israel (Reuters) - Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Health | Israel Health | Middle East Health | Pharmaceuticals